Different therapeutic responses to osimertinib as first-line treatment for cavitated and non-cavitated squamous cell lung cancer with rare EGFR exon 19 deletion: two case reports and a literature review

BackgroundCavitation is a special radiological feature of lung cancer, commonly observed in squamous cell lung cancer (SqCLC). This study intended to report two cases of cavitated and non-cavitated SqCLCs treated with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and discus...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Jing Ren, Liang Xiao Cheng, Rui Zhang, Zhi Zou, Yongzhao Zhou, Xi Zheng
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Frontiers Media S.A. 2025-10-01
Seri Bilgileri:	Frontiers in Oncology
Konular:	squamous cell lung cancer cavitation non-cavitated epidermal growth factor receptor tyrosine kinase inhibitors osimertinib
Online Erişim:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1626665/full
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!